NCT05535634 is a clinical trial of Sound Ear Check in Hearing Loss, sponsored by Vesa Lahdes.

Who is sponsoring NCT05535634?

NCT05535634 is sponsored by Vesa Lahdes.

What drugs are being tested in NCT05535634?

Interventions in NCT05535634: Sound Ear Check.

What condition does NCT05535634 study?

NCT05535634 studies Hearing Loss, Otitis Media With Effusion, Tympanostomy.

Is NCT05535634 still recruiting?

NCT05535634 is currently recruiting now. Last updated 10 September 2022.

Last reviewed 2022-09-10 · How we verify

NCT05535634

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sound Ear Check (SEC) in Hearing Diagnostics in Young Children

Recruiting now Last updated 10 September 2022

What this trial tests

trial testing Sound Ear Check in Hearing Loss in 100 participants. Currently enrolling.

Timeline

31 August 2022

Primary endpoint
31 December 2028

31 December 2028

Quick facts

Lead sponsor	Vesa Lahdes
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	31 August 2022
Primary completion	31 December 2028
Estimated completion	31 December 2028
Sites	1 location across Finland

Drugs / interventions tested

Sound Ear Check

Conditions studied

Hearing Loss — all drugs for Hearing Loss →
Otitis Media With Effusion — all drugs for Otitis Media With Effusion →
Tympanostomy — all drugs for Tympanostomy →

Sponsor

Vesa Lahdes

Who can join

Adults 3 to 10, any sex, with Hearing Loss or Otitis Media With Effusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study Sound Ear Check (SEC) hearing test among 3-10 years old otherwise healthy children referred to tympanostomy tube placement. SEC test prior surgery (with middle ear fluid) and at 1 month control visit (dry middle ear with ventilation tube). Otitis media 6 questionnaire prior surgery and at the 1 month control visit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hearing Loss

Currently open trials in the same condition.

NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05535634 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vesa Lahdes
Last refreshed: 10 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05535634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing